Hear the latest developments in endocrine pathology and oncology from nationally and internationally recognised experts in the field. Join us for a two-day update on endocrine pathology. Accredited by RCPath for 10 CPD points, covering topics including
- Updated WHO Classification of Endocrine & Neuroendocrine Tumours of thyroid, parathyroid, adrenal cortex & phaeochromocytoma/paraganglioma
- Updates to RCPath datasets for carcinoma of thyroid, parathyroid, adrenal cortex & paraganglioma
- MDT’s & national guidelines
- Surgical approaches to thyroid cancer & pathology
- Reporting thyroid cytology using the UK ‘Thy’ system & discussion of the Bethesda system
- Risk stratification in thyroid cancer
- Pitfalls in thyroid diagnosis & medicolegal issues
- The thyroid patient. What the oncologist needs from pathology
- Update on new therapies & clinical trials for thyroid cancer
- Artificial intelligence & digital pathology in endocrine pathology
- Multidisciplinary working
- Case based discussions
The London Endocrine Pathology Update, Monday and Tuesday 10th and 11th February, 2025
The Gordon Museum of Pathology, Guy’s Campus, London, SE1 1UL
Location Map for The Gordon Museum
Day 1: 10th February, 2025
9.15 Welcome & introductory remarks
Dr David Poller, Queen Alexandra Hospital, Portsmouth
9.30 WHO 2023 Update on Thyroid Tumours: An overview
Professor Giovanni Tallini, University of Bologna, Italy
10.00 WHO 2023 Update on Parathyroid Tumours: An overview
Dr Sonali Natu, University Hospital of North Tees, Stockton on Tees
10.30 WHO 2023 Update on Adrenal Tumours: An overview
Dr Mufaddal Moonim, Imperial College Healthcare NHS Trust, London
11.00 Questions & Answers
11.15 Break
11.30 General Guideline Overview (RCPath, ICCR, BTA, NICE) Thyroid/Parathyroid/Adrenal Dr Mufaddal Moonim, Imperial College Healthcare NHS Trust, London
12.00 RCPath ‘Thy’ Cytology & other International Thyroid FNA Reporting Terminologies Dr David Poller, Queen Alexandra Hospital, Portsmouth
12.30 Questions & Answers
12.45 Lunch
13.45 Risk Stratification in Thyroid Cancer
Dr Ronald Ghossein, Memorial Sloan Kettering Cancer Center, New York, USA
14.30 Surgical approaches to thyroid cancer
Prof. Neil Tolley, Imperial College Healthcare NHS Trust, London, UK
15.15 Questions & Answers
15.30 Break
15.45 Interactive Question & Answer forum – all speakers
16.15 Meeting Close
Day 2: 11th February 2025
9.15 Welcome
Dr Mufaddal Moonim, Imperial College Healthcare NHS Trust, London
9.30 Thyroid Cancer Patient- trials & therapies & what oncologist needs to know Dr Kate Newbold, Royal Marsden Hospital, London, UK
10.15 Molecular Pathology of thyroid cancer
Dr Bin Xu, Memorial Sloan Kettering Cancer Center, New York, USA
11.00 Questions & Answers
11.15 Break
11.30 Pitfalls & Medicolegal Issues in thyroid & parathyroid
Dr Ronald Ghossein, Memorial Sloan Kettering Cancer Center, New York, USA
12.15 AI and Digital Pathology in Endocrine Pathology
Prof. Nasir Rajpoot, University of Warwick, UK
12.45 Questions & Answers
13.00 Lunch
13.45 Part 1 Interactive forum with case-based discussions
Dr Matthews (chair) UHCW, Coventry, UK + all speakers
14.30 Break
14.45 Part 2 Interactive forum with case-based discussions
Dr Matthews (chair) UHCW, Coventry, UK + all speakers
15.30 Closing remarks
